CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 67 filers reported holding CTI BIOPHARMA CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $64,000 | +120.7% | 157,381 | +83.7% | 0.00% | – |
| Q2 2016 | $29,000 | -56.1% | 85,665 | -31.7% | 0.00% | – |
| Q1 2016 | $66,000 | -93.3% | 125,400 | -84.4% | 0.00% | – |
| Q4 2015 | $990,000 | -12.9% | 804,297 | +3.3% | 0.00% | – |
| Q3 2015 | $1,136,000 | -29.4% | 778,615 | -5.7% | 0.00% | – |
| Q2 2015 | $1,610,000 | -23.8% | 825,372 | -29.3% | 0.00% | -100.0% |
| Q1 2015 | $2,113,000 | +2.9% | 1,167,321 | +34.2% | 0.00% | – |
| Q4 2014 | $2,053,000 | +98.2% | 869,738 | +103.2% | 0.00% | – |
| Q3 2014 | $1,036,000 | -47.8% | 428,100 | -39.4% | 0.00% | -100.0% |
| Q2 2014 | $1,986,000 | – | 707,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|